Kwangdong Healthbio Statistics

Total Valuation

XKON:086220 has a market cap or net worth of KRW 18.02 billion.

Market Cap	18.02B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

XKON:086220 has 12.69 million shares outstanding.

Current Share Class	12.69M
Shares Outstanding	12.69M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.61%
Float	2.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.47
PB Ratio	1.52
P/TBV Ratio	1.58
P/FCF Ratio	51.44
P/OCF Ratio	30.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.52, with a Debt / Equity ratio of 1.64.

Current Ratio	0.52
Quick Ratio	0.22
Debt / Equity	1.64
Debt / EBITDA	7.33
Debt / FCF	55.56
Interest Coverage	1.07

Financial Efficiency

Return on equity (ROE) is -4.15% and return on invested capital (ROIC) is 3.40%.

Return on Equity (ROE)	-4.15%
Return on Assets (ROA)	1.62%
Return on Invested Capital (ROIC)	3.40%
Return on Capital Employed (ROCE)	7.35%
Weighted Average Cost of Capital (WACC)	3.76%
Revenue Per Employee	470.33M
Profits Per Employee	-3.99M
Employee Count	81
Asset Turnover	0.96
Inventory Turnover	6.50

Taxes

In the past 12 months, XKON:086220 has paid 45.81 million in taxes.

Income Tax	45.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.81% in the last 52 weeks. The beta is -0.11, so XKON:086220's price volatility has been lower than the market average.

Beta (5Y)	-0.11
52-Week Price Change	+21.81%
50-Day Moving Average	1,424.48
200-Day Moving Average	1,438.17
Relative Strength Index (RSI)	50.20
Average Volume (20 Days)	726

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XKON:086220 had revenue of KRW 38.10 billion and -323.52 million in losses. Loss per share was -57.00.

Revenue	38.10B
Gross Profit	5.05B
Operating Income	1.03B
Pretax Income	-277.71M
Net Income	-323.52M
EBITDA	2.66B
EBIT	1.03B
Loss Per Share	-57.00

Full Income Statement

Balance Sheet

The company has 1.28 billion in cash and 19.46 billion in debt, giving a net cash position of -18.18 billion or -1,432.96 per share.

Cash & Cash Equivalents	1.28B
Total Debt	19.46B
Net Cash	-18.18B
Net Cash Per Share	-1,432.96
Equity (Book Value)	11.83B
Book Value Per Share	2,084.52
Working Capital	-12.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 583.50 million and capital expenditures -233.24 million, giving a free cash flow of 350.26 million.

Operating Cash Flow	583.50M
Capital Expenditures	-233.24M
Free Cash Flow	350.26M
FCF Per Share	27.61

Full Cash Flow Statement

Margins

Gross margin is 13.27%, with operating and profit margins of 2.69% and -0.85%.

Gross Margin	13.27%
Operating Margin	2.69%
Pretax Margin	-0.73%
Profit Margin	-0.85%
EBITDA Margin	6.97%
EBIT Margin	2.69%
FCF Margin	0.92%

Dividends & Yields

XKON:086220 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	33.03%
Shareholder Yield	33.03%
Earnings Yield	-1.80%
FCF Yield	1.94%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XKON:086220 has an Altman Z-Score of 0.77 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.77
Piotroski F-Score	6